: Key Takeaways: In a significant stride towards revolutionizing biomedical research, CryoLogyx, a pioneering spinout from the University of Warwick, has successfully concluded a £500k seed funding round. This funding, spearheaded by private UK business angels and the Wider Oxford Technology Angel Network (WOTAN), marks a crucial milestone in the advancement of cryopreserved cell technology. Let’s delve into the details of this groundbreaking development and its implications for the future of life sciences. CryoLogyx: Redefining Cell Technology Founded in 2020 by CEO Dr. Tom Congdon and CSO Prof. Matt Gibson, CryoLogyx emerges as a frontrunner in the realm of cryopreservation, offering The post Breakthrough Funding Fuels Innovation in Cryopreservation: What You Need to Know appearedfirst on Business Today
: Key Takeaways: Armalytix: A Driving Force in Property Transactions In a groundbreaking development, Armalytix, the leading UK-based data intelligence firm specializing in source of funds and affordability checks, has emerged as the driving force behind legal firms responsible for 1 in 8 residential property transactions conducted in England and Wales. Within just two years since its market introduction, Armalytix’s technologyhas rapidly evolved into the foremost provider for legal firms engaged in property transactions. A Year of Success: Recognitions and Uptake Following a successful 2023 marked by nominations for Modern Law and the British Conveyancing Awards, Armalytix has witnessed a The post Revealed: The Secret Behind 1 in 8 Property Transactions in England and Wales! appearedfirst on Business Today